National Thrombosis Seminars
CanVECTOR Thrombosis Research Seminars are a series of live, monthly, virtual webinars featuring state-of-the-art venous thromboembolism (VTE) lectures presented by both Canadian and international experts! The 2025-2026 series runs from November 2025 – May 2026.
Registration is free and attendees are eligible for CME credits as the CanVECTOR National Thrombosis Seminars is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Latest Seminar
Working towards precision in DOAC reversal through harnessing the power of a national, trainee-led network in the UK
June 8, 2026 – 12:00-12:45pm (ET)
Featuring:
- Richard Buka, PhD, MBChB – University of Birmingham
Past Seminars
- Post-Thrombotic Syndrome: From Clinical Insights to Machine Learning
- Multiplex Protein Profiling in Thrombosis and Hemostasis: What Can We Measure and What Can We Learn?
- Periprocedural Anticoagulation Management for Central Line Insertion in Persons with Cancer
- Biomarkers and Genetics for the Prediction of Venous Thromboembolism and Clinically Relevant Bleeding in Cancer Patients
- Anticoagulation in 2025 Lessons from recent clinical studies
- Global Burden of VTE – What we can infer and the road ahead
- Anticoagulant and Antiplatelet Prescribing in 2024: When Less is More
- Platelet Procoagulant Membrane Dynamics (PMD) Study – Mechanistic Insights and Clinical Translation
- Catheter-directed Thrombectomy and ICU Care of PE
- Antiphospholipid Syndrome: New Criteria, New Era?
- Transgender Health and VTE
- Thromboprophylaxis in Hospitalized Acutely-ill Older Adult Medical Patients – The SYMPTOMS Trial
- Innovative Pragmatic Trial Design: The iTADS Trial
- News at XI – Moving Beyond the Factor Xa Inhibitors
- Use of Oral Anticoagulation in Patients with End-Stage Renal Disease
- Whether, When, and How to Restart Anticoagulation after Bleeding
- Disrupting Paradigms in the Diagnosis of Pulmonary Embolism
- 2022 ACCP Guidelines on Perioperative Antithrombotic Management: Controversies, Evidence Gaps, Future Research
- LMWH and Cancer Mortality: Basic Science for Pathophysiology with Insights from the PERIOP-01 Trial
- Prevention of VTE in pregnancy – are we making progress?
- Medical treatment of PTS – What are our options? What is the MUFFIN Trial?
- Outreach and Opportunity: Patient Engagement in VTE Research
- Trials and Tribulations of Claims-Based VTE Research
- Venous Thromboembolism in Sickle Cell Disease: Risk, Prevention, and Management
- A Long Journey in the Subsegmental Underworld of Pulmonary Embolism
- Complement and Thrombosis
- Specificities of Pediatric Thrombosis Management
- Testing for Venous Thrombosis: How can D-Dimer be your Friend?
- Bleeding & Anticoagulation
- Thrombosis / Thromboprophylaxis in Patients with Myeloproliferative Neoplasms
- Maternal Health & VTE
- Statins & VTE Research
- Malignancy Screening in Patients with Unprovoked VTE
- COVID-19-VTE Research: Concept of Immunothrombosis